Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 68.90 | 22.02 |
| PEG Ratio (TTM) | -7.58 | -0.09 |
| P/S Ratio (TTM) | 1.54 | 3.04 |
| P/B Ratio (TTM) | 1.89 | 1.62 |
| P/FCF Ratio (TTM) | 12.19 | 36.70 |
| Price to 5YR AVG Earnings Ratio | N/A | 40.81 |
| Price to 5YR AVG FCF Ratio | N/A | 44.13 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.34% | 10.87% |
| ROE (TTM) | 2.83% | -10.79% |
| Net Profit Margin (TTM) | 2.23% | 12.39% |
| ROIC 5YR AVG | N/A | 22.04% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -1,705.05% | -99.89% | N/A |
| Revenue | 4.25% | 31.17% | N/A |
| Net Income | -1,751.59% | -94.96% | N/A |
| Cash Flow | -11.19% | 8.80% | N/A |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.44 | 1.58 |
| Quick Ratio (TTM) | 1.60 | 1.10 |
| D/E Ratio (TTM) | 0.68 | -0.31 |
| Interest Coverage (TTM) | 0.84 | 13.07 |
| Piotroski F-Score | 4 | 7 |
| Altman Z-Score | 1.89 | 5.04 |
| LTL to 5YR AVG FCF | N/A | 6.91 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.72% |